We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Clinical Trial Assesses Anti-clotting Drug for Treatment of COVID-19-related Respiratory Failure

News   Apr 07, 2020 | Original story from Beth Israel Deaconess Medical Center

 
Clinical Trial Assesses Anti-clotting Drug for Treatment of COVID-19-related Respiratory Failure
 
 
Advertisement
 

RELATED ARTICLES

Two Biomarkers Help Predict Immunotherapy Response in Metastatic Breast Cancer

News

Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit.

READ MORE

Not Enough Women and Older Adults in Cholesterol Drug Trials, Study Suggests

News

Johns Hopkins Medicine researchers report that although some progress has been made — women and older adults are still underrepresented in lipid lowering therapy trials compared with their disease burden.

READ MORE

Inherited Genetics Can Drive Spread of Skin Cancer

News

Sometimes cancer stays put, but often it metastasizes to other locations within the body. It has long been suspected that genetic mutations arising inside tumor cells drive this potentially devastating turn of events. A new study now suggests that differences in a single gene, carried within someone’s genome from birth, can alter progression of melanoma, a type of skin cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE